Profound Medical Corp. Presentation Now Available for On-Demand Viewing

About this update from Profound Medical Corp

[{"type":"text","content":"\n\n\n\nProfound Medical Corp. Presentation Now Available for On-Demand Viewing\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMISSISSAUGA, Ontario, May 15, 2017\n\n\n\nCompany invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation\n\n\n\nMISSISSAUGA, Ontario, May 15, 2017 /CNW/ -- Profound Medical Corp. (OTCQX: PRFMF) (TSX-V: PRN), based in Ontario, an emerging medical device company focused on prostate care, today announced that the May 11 presentation from CEO, Arun Menawat, is now available for on-demand viewing at VirtualInvestorConferences.com. \n\n\n\nLINK: https://tinyurl.com/0511postpr\n\nProfound Medical Corp.'s presentation will be available 24/7 for 90 days. Investors and advisors may download shareholder materials from the \"virtual trade booth\" for the next three weeks.\n\nRecent Company Highlights\n\n\nProfound Medical Corp. announced its common shares are available for trading on the OTCQX® Best Mark starting March 13, 2017\nProfound Medical Corp. announced on April 18th it secured Depository Trust Company (DTC) eligibility for its shares traded on the OTCQX market. \nAbout Profound Medical Corp.The Profound Medical team is committed to the effort to achieve a new therapeutic standard in prostate cancer. For the millions of men currently living with prostate cancer, and the thousands more who are diagnosed with it every year, current treatment options often mean having to make difficult choices based on potential side effects that can significantly impact quality of life.  Our mission is to profoundly change the standard of care by creating a tomorrow where clinicians can confidently ablate cancerous prostate tissue with precision, while actively protecting critical anatomy from potential side effects; a tomorrow where patients have access to a safe, fast and effective treatment option, so they can quickly return to their daily lives.\n\nEstablished in 2008, Profound Medical is commercializing a novel technology, TULSA-PRO™, which c...

More updates from Profound Medical Corp